Capturing multiple-type interactions into practical predictors of type replacement following human papillomavirus vaccination.

Abstract

Current HPV vaccines target a subset of the oncogenic human papillomavirus (HPV) types. If HPV types compete during infection, vaccination may trigger replacement by the non-targeted types. Existing approaches to assess the risk of type replacement have focused on detecting competitive interactions between pairs of vaccine and non-vaccine types. However, methods to translate any inferred pairwise interactions into predictors of replacement have been lacking. In this paper, we develop practical predictors of type replacement in a multi-type setting, readily estimable from pre-vaccination longitudinal or cross-sectional prevalence data. The predictors we propose for replacement by individual non-targeted types take the form of weighted cross-hazard ratios of acquisition versus clearance, or aggregate odds ratios of coinfection with the vaccine types. We elucidate how the hazard-based predictors incorporate potentially heterogeneous direct and indirect type interactions by appropriately weighting type-specific hazards and show when they are equivalent to the odds-based predictors. Additionally, pooling type-specific predictors proves to be useful for predicting increase in the overall non-vaccine-type prevalence. Using simulations, we demonstrate good performance of the predictors under different interaction structures. We discuss potential applications and limitations of the proposed methodology in predicting type replacement, as compared to existing approaches. This article is part of the theme issue 'Silent cancer agents: multi-disciplinary modelling of human DNA oncoviruses'.

• Authors: Irene Man, Kari Auranen, Jacco Wallinga, Johannes A Bogaards
• Journal: Philosophical transactions of the Royal Society of London. Series B, Biological sciences (Philos Trans R Soc Lond B Biol Sci) Vol. 374 Issue 1773 Pg. 20180298 (05 27 2019) ISSN: 1471-2970 [Electronic] England
• PMID: 30955490 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Papillomavirus Vaccines

Topics

• Cross-Sectional Studies
• Humans
• Longitudinal Studies
• Models, Theoretical
• Papillomaviridae (immunology)
• Papillomavirus Infections (immunology)
• Papillomavirus Vaccines (therapeutic use)
• Vaccination (statistics & numerical data)